Entera Bio Ltd. - ROE
ENTX
Price:
$1.21
Market Cap:
$59.64M
Entera Bio Ltd. is a biopharmaceutical firm in the clinical development phase, dedicated to creating and marketing oral medications composed of large molecules, addressing medical conditions that currently lack adequate treatments. Its primary experimental drugs are EB612, currently undergoing Phase II clinical assessment for hypoparathyroidism, and EB613, which has concluded Phase II studies for osteoporosis and is now in Phase I trials for treating non-healing bone fractures. Furthermore, the company holds a collaborative research and licensing pact with Amgen Inc. aimed at identifying and advancing potential therapeutic compounds for inflammatory conditions and other grave ailments. Estab...[Read more]
Industry
Biotechnology
IPO Date
2018-06-28
Stock Exchange
NASDAQ
Ticker
ENTX
PE Ratio
[-4.65]
ROE
[-87.97%]
Current Ratio
[7.93]
Dividend Yield
[0%]
Enterprise Value
[55.95M]
Dividend History
The ROE as of June 2026 (TTM) for Entera Bio Ltd. (ENTX) is -87.97%
According to Entera Bio Ltd.’s latest financial reports and current stock price. The company's current ROE is -87.97%. This represents a change of 281.59% compared to the average of -23.05% of the last 4 quarters.
Entera Bio Ltd. (ENTX) Historical ROE (quarterly & annually)
How has ENTX ROE performed in the past?
The mean historical ROE of Entera Bio Ltd. over the last ten years is -75.77%. The current -87.97% ROE has changed 16.10% with respect to the historical average. Over the past ten years (40 quarters), ENTX's ROE was at its highest in in the December 2021 quarter at 21.79%. The ROE was at its lowest in in the September 2019 quarter at -74.15%.
Average
-75.77%
Median
-88.94%
Minimum
-149.35%
Maximum
35.48%
Entera Bio Ltd. (ENTX) ROE by Quarter and Year
Discovering the peaks and valleys of Entera Bio Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 647.08%
Maximum Annual ROE = 35.48%
Minimum Annual Increase = -387.08%
Minimum Annual ROE = -149.35%
| Year | ROE | Change |
|---|---|---|
| 2025 | -87.31% | -26.06% |
| 2024 | -118.08% | 37.97% |
| 2023 | -85.59% | -23.04% |
| 2022 | -111.20% | 105.90% |
| 2021 | -54.01% | -63.84% |
| 2020 | -149.35% | 64.90% |
| 2019 | -90.57% | -11.08% |
| 2018 | -101.86% | -387.08% |
| 2017 | 35.48% | 647.08% |
| 2016 | 4.75% | -71.51% |
Entera Bio Ltd. (ENTX) Average ROE
How has ENTX ROE performed in the past?
The current ROE of Entera Bio Ltd. (ENTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-96.99%
5-year avg
-91.24%
10-year avg
-75.77%
Entera Bio Ltd. (ENTX) ROE vs. Peers
How is ENTX’s ROE compared to its peers?
Entera Bio Ltd.’s ROE is greater than Anixa Biosciences, Inc. (-65.73%), greater than VistaGen Therapeutics, Inc. (-133.02%), less than Opus Genetics, Inc. (6.07%), greater than Seer, Inc. (-26.58%), greater than TuHURA Biosciences, Inc. (-153.99%), greater than Acumen Pharmaceuticals, Inc. (-123.07%), greater than Seres Therapeutics, Inc. (-127.30%), less than Spero Therapeutics, Inc. (35.58%), greater than Agenus Inc. (-23.05%), greater than Inovio Pharmaceuticals, Inc. (-666.47%),
| Company | ROE | Market cap |
|---|---|---|
| -65.73% | $99.01M | |
| -133.02% | $21.96M | |
| 6.07% | $336.04M | |
| -26.58% | $95.67M | |
| -153.99% | $163.66M | |
| -123.07% | $136.90M | |
| -127.30% | $64.01M | |
| 35.58% | $132.02M | |
| -23.05% | $124.93M | |
| -666.47% | $59.75M |
Build a custom stock screener for Entera Bio Ltd. (ENTX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entera Bio Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Entera Bio Ltd. (ENTX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Entera Bio Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Entera Bio Ltd.'s ROE?
How is the ROE calculated for Entera Bio Ltd. (ENTX)?
What is the highest ROE for Entera Bio Ltd. (ENTX)?
What is the 3-year average ROE for Entera Bio Ltd. (ENTX)?
What is the 5-year average ROE for Entera Bio Ltd. (ENTX)?
How does the current ROE for Entera Bio Ltd. (ENTX) compare to its historical average?